PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2148735
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2148735
Cementless Neck Stems Market is estimated to be valued at USD 3.85 Bn in 2026 and is expected to reach USD 5.49 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.2% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 3.85 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.20% | 2033 Value Projection: | USD 5.49 Bn |
The market is witnessing steady growth mainly driven by the increasing volume of total hip arthroplasty procedures, rising preference for cementless femoral fixation, growing demand from younger and more active patients, and advancements in porous coatings and implant surface technologies that promote biological fixation and long-term osseointegration. Cementless neck stems are femoral components used in hip arthroplasty that achieve fixation without bone cement by providing initial mechanical stability followed by biological fixation and bone integration.
The market is increasingly shifting toward advanced cementless stem designs that improve initial fixation, preserve proximal femoral bone, and reduce the risk of complications such as aseptic loosening and periprosthetic femoral fractures. Collared stems, short stems, metaphyseal-fixing designs, and bone-preserving implants are gaining clinical attention as orthopedic manufacturers seek to improve long-term survivorship and facilitate potential future revision procedures.
Healthcare providers are increasingly focusing on patient-specific selection of femoral stems based on age, bone quality, anatomy, and fracture risk. Growing adoption of tissue-sparing surgical approaches, robotic-assisted orthopedic surgery, navigation systems, and digitally assisted hip replacement procedures is also supporting the evolution of cementless hip arthroplasty. Expanding joint-replacement capacity across emerging markets and increasing access to advanced orthopedic implants are expected to further support market growth over the forecast period.
The Cementless Neck Stems Market is witnessing significant momentum owing to the increasing number of primary total hip arthroplasty procedures worldwide. Rising prevalence of osteoarthritis, population aging, improving access to orthopedic surgery, and increasing willingness among patients to undergo joint replacement procedures are expanding the addressable patient population for cementless femoral stems.
The growing preference for cementless femoral fixation is another major factor supporting market expansion. Cementless stems provide mechanical stability followed by biological fixation and osseointegration, making them particularly suitable for appropriately selected patients with adequate bone quality. Advancements in porous coatings, implant surface technologies, stem geometry, and bone-preserving designs are improving fixation and long-term clinical outcomes.
Increasing adoption of short and collared cementless stems is also shaping market development. Short stems help preserve proximal femoral bone and may facilitate future revision procedures, while collared stem designs are increasingly being used to improve initial stability and reduce the risk of loosening and periprosthetic fractures. These developments are particularly relevant for younger and more active patients who require durable long-term fixation.
The expansion of specialized orthopedic centers and joint replacement programs is further supporting demand. Private hospitals are increasingly adopting premium orthopedic implants, robotic-assisted surgery, advanced navigation systems, and digitally supported joint replacement technologies. At the same time, healthcare systems are placing greater emphasis on clinical outcomes, complication rates, readmissions, implant survivorship, and overall episode-of-care costs.
However, high implant and procedure costs and the risk of intraoperative femoral fracture remain important challenges for market growth. Patient-specific risk assessment and appropriate selection between cementless and cemented fixation are therefore expected to remain important considerations in clinical practice.